The importance and use of the Drosophila sp. as an animal model has revolutionized the field of genetics and molecular biology. In 1909, T.H. Morgan used the fruit flies for the first time in his laboratory. Since that day many milestone discoveries have been made in the field Continue reading The fly saga: How Drosophila became the queen of genetics
A study found that blood (serum) collected after a single bout of exercise (‘acute exercise’) was able to reduce cancer cell growth. Interestingly, serum collected at rest but after 6-months of exercise training had no effect. This suggests that the biochemical changes involved in the acute response to exercise can have direct anti-cancer effects. Continue reading Exercise protects against cancer – but how?
This is the second part of our commentary in which we look at the ways in which ideas of responsible research and innovation (RRI) are discussed in recent UK discourse on industrial biotechnology (IB) innovation, in particular the UK’s National IB Strategy to 2030. Continue reading Part 2 – The UK National Industrial Biotechnology Strategy to 2030: What is the role for responsible research and innovation?
London, June 6, 2018. Leaders and luminaries from the UK biotech industry, academia and policy community gather at an event in Parliament to launch the UK’s National Strategy for the IB sector. Organized by the UK Bioindustry Association (BIA) and hosted by Daniel Zeichner, the MP for Cambridge, the event introduced a report that set out an ambitious vision and roadmap for the UK IB sector from 2018-2030. Continue reading Part 1 – The National Industry Biotechnology Strategy to 2030: What is the role for responsible research and innovation?